Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arrowhead Pharma (NQ: ARWR )

82.07 USD +2.05 (+2.56%)
Official Closing Price Updated: 7:48 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Arrowhead Pharma

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Earnings Scheduled For November 23, 2020
Companies Reporting Before The Bell • Baozun (NASDAQ:BZUN) is expected to report quarterly earnings at $0.20 per share ... 
Tags URBN CENTA GWGH
From Benzinga
Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates
Biotech stocks came under pressure in the week ended Nov. 20, reversing course from the previous week. The sector started the week on a strong note, thanks to positive vaccine data reported by Moderna... 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
The Week Ahead In Biotech: Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates
Biotech stocks came under pressure in the week ended Nov. 20, reversing course from the previous week. The sector started the week on a ... 
Tags RYTM SQZ Trading Ideas
From Benzinga
Benzinga's Top Upgrades, Downgrades For November 19, 2020
Upgrades According to MKM Partners, the prior rating for Target Corp (NYSE: TGT) was changed from Sell to Neutral. Target earned ... 
Tags STT NRIX ARWR
From Benzinga
Notable ETF Inflow Detected - XBI, ARWR, FOLD, MRTX
Symbols mentioned in this story: XBI, ARWR, FOLD, MRTX Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Arrowhead Presents New Clinical Data on Cardiometabolic Pipeline at AHA 2020
Arrowhead announced positive clinical data from multiple product candidates in its cardiometabolic pipeline at the American Heart Association 
From Business Wire News Releases
Arrowhead Interim Clinical Data Demonstrate ARO-AAT Treatment Improved Multiple Biomarkers of Alpha-1 Liver Disease
Arrowhead announced positive interim clinical data at The AASLD Liver Meeting Digital Experience 
From Business Wire News Releases
Arrowhead Pharmaceuticals to Participate in Upcoming Conferences
Arrowhead Pharmaceuticals will Participate in multiple Upcoming November 2020 Conferences 
From Business Wire News Releases
Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinars on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3
Arrowhead will host KOL webinars on two investigational RNAi based cardiometabolic candidates ARO-APOC3 and ARO-ANG3 
From Business Wire News Releases
Arrowhead Pharmaceuticals to Webcast Fiscal 2020 Year End Results
Arrowhead Pharmaceuticals will webcast its fiscal 2020 year end earnings 
From Business Wire News Releases
Notable ETF Outflow Detected - XBI, ARWR, EXAS, BPMC
Symbols mentioned in this story: XBI, ARWR, EXAS, BPMC Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Noteworthy ETF Outflows: XBI, IMMU, ARWR, BPMC
Symbols mentioned in this story: XBI, IMMU, ARWR, BPMC Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Arrowhead Pharma Shows Market Leadership With Jump To 83 RS Rating
Arrowhead Pharma shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 67 to 83. 
From Investor's Business Daily
56 Biggest Movers From Yesterday
Gainers Replimune Group, Inc. (NASDAQ: REPL) shares rose 132% to close at $40.97. HC Wainwright & Co. upgraded Replimune ... 
Tags AVXL Market News TLRY
From Benzinga
Vertex Tumbles As It Stops Testing On Protein Deficiency Treatment
Shares of Vertex plunged after hours Wednesday after the company announced it planned to stop testing on a drug designed to treat protein deficiencies. VRTX stock fell by double digits. 
From Investor's Business Daily
Why Arrowhead Pharmaceuticals Is Trading Higher Today
Arrowhead Pharmaceuticals (NASDAQ: ARWR) shares are trading higher on Thursday on news that Vertex Pharmaceuticals discontinued its ... 
Tags News ARWR Benzinga
From Benzinga
45 Stocks Moving In Thursday's Mid-Day Session
Gainers Staffing 360 Solutions, Inc. (NASDAQ: STAF) shares jumped 146.1% to $1.9345 after surging around 24% on Wednesday. ... 
Tags Intraday Update NETE Markets
From Benzinga
Looking Into Arrowhead Pharmaceuticals's Return On Capital Employed
Arrowhead Pharmaceuticals (NASDAQ: ARWR) reported Q3 sales of $27.38 million. Earnings fell to a loss of $15.95 million, resulting in a ... 
Tags Market News General Benzinga
From Benzinga
Thinking about trading options or stock in Arrowhead Pharmaceuticals, Nio Inc, Raven Industries, Apple, or Carnival Corp?
InvestorsObserver issues critical PriceWatch Alerts for ARWR, NIO, RAVN, AAPL, and CCL. 
From PR Newswire
12 Healthcare Stocks Moving In Thursday's Pre-Market Session
Gainers Anavex Life Sciences (NASDAQ:AVXL) stock moved upwards by 31.1% to $5.69 during Thursday's pre-market session. The ... 
Tags AVXL Market News ORGO
From Benzinga
50 Stocks Moving in Thursday's Pre-Market Session
Gainers Staffing 360 Solutions, Inc. (NASDAQ: STAF) rose 82% to $1.43 in pre-market trading after surging around 24% on Wednesday. ... 
Tags PLUG Top Gainers APHA
From Benzinga
Vertex Tumbles As It Stops Testing On Protein Deficiency Treatment
Shares of Vertex plunged after hours Wednesday after the company announced it planned to stop testing on a drug designed to treat protein deficiencies. VRTX stock fell by double digits. 
From Investor's Business Daily
Dow Jones Futures: Stimulus Deal Doubts Pause Stock Market Rally; Tesla, Nio Break Out; Fastly, Vertex Dive Late
Dow Jones futures: Stimulus deal doubts nicked the stock market rally, which still looks healthy. Tesla and EV rival Nio broke out. Fastly and Vertex Pharma crashed late on news. 
From Investor's Business Daily
13 Stocks Moving In Wednesday's After-Hours Session
Gainers Sleep Number (NASDAQ: SNBR) shares are trading higher after the company reported better-than-expected Q3 EPS and sales ... 
Tags BE NET SNBR
From Benzinga
Thinking about trading options or stock in General Electric, Roku, CareDx Inc, Arrowhead Pharmaceuticals, or Eli Lilly?
InvestorsObserver issues critical PriceWatch Alerts for GE, ROKU, CDNA, ARWR, and LLY. 
From PR Newswire
Takeda and Arrowhead Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease
Takeda and Arrowhead announced a collaboration and licensing agreement to develop ARO-AAT, a Ph. 2 investigational RNAi therapy to treat AATLD. 
From Business Wire News Releases
Peek Under The Hood: EWMC Has 15% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Arrowhead Pharmaceuticals to Participate in Upcoming Investor Conference
Arrowhead to participate in Chardan Genetic Medicines Conference 
From Business Wire News Releases
Arrowhead Pharmaceuticals Moves Up In Market Cap Rank, Passing People's United Financial
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Arrowhead Pharmaceuticals Inc (ARWR) was identified as having a larger market cap than the smaller end of... 
Tags Stocks
From Market News Video
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
Arrowhead reports inducement grants 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.